AG˹ٷ

STOCK TITAN

[Form 4] Canopy Growth Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Dillard’s, Inc. (DDS) Form 4 filing dated 07/02/2025 discloses a modest open-market purchase by long-time insider Drue Matheny, Executive Vice President and Director. On 06/30/2025 Matheny acquired 19 Class A common shares at $413.32 each, increasing her direct holding to 403,904 shares. She also continues to hold 36,648 shares through the company retirement plan and 9,821 shares indirectly (7,300 as trustee of the GST Trust and 2,521 held by her spouse). No derivative transactions were reported.

The purchase represents less than 0.005% of her direct ownership and is immaterial to DDS’s 17 million share float, yet any insider buying—particularly by a senior executive—may be interpreted as a confidence signal. There were no sales, option exercises, or 10b5-1 plan indications, and the filing confirms her continuing status as both officer and director.

Il modulo Form 4 di Dillard’s, Inc. (DDS) datato 02/07/2025 rivela un modesto acquisto sul mercato aperto da parte della veterana insider Drue Matheny, Vicepresidente Esecutivo e Direttrice. Il 30/06/2025 Matheny ha acquisito 19 azioni ordinarie di Classe A a $413,32 ciascuna, portando la sua partecipazione diretta a 403.904 azioni. Continua inoltre a detenere 36.648 azioni attraverso il piano pensionistico aziendale e 9.821 azioni indirettamente (7.300 come fiduciaria del GST Trust e 2.521 detenute dal coniuge). Non sono state segnalate transazioni su strumenti derivati.

L’acquisto rappresenta meno dello 0,005% della sua proprietà diretta ed è irrilevante rispetto alle 17 milioni di azioni in circolazione di DDS, tuttavia qualsiasi acquisto da parte di un insider—soprattutto di un dirigente senior—può essere interpretato come un segnale di fiducia. Non ci sono state vendite, esercizi di opzioni o indicazioni di piani 10b5-1, e la comunicazione conferma il suo status continuativo come dirigente e direttrice.

La presentación del Formulario 4 de Dillard’s, Inc. (DDS) con fecha 02/07/2025 revela una modesta compra en el mercado abierto por parte de la veterana insider Drue Matheny, Vicepresidenta Ejecutiva y Directora. El 30/06/2025 Matheny adquirió 19 acciones comunes Clase A a $413.32 cada una, aumentando su participación directa a 403,904 acciones. También mantiene 36,648 acciones a través del plan de jubilación de la empresa y 9,821 acciones indirectamente (7,300 como fideicomisaria del GST Trust y 2,521 en posesión de su cónyuge). No se reportaron transacciones con derivados.

La compra representa menos del 0.005% de su propiedad directa y es insignificante en relación con las 17 millones de acciones en circulación de DDS, pero cualquier compra por parte de un insider—especialmente un ejecutivo senior—puede interpretarse como una señal de confianza. No hubo ventas, ejercicios de opciones ni indicios de planes 10b5-1, y la presentación confirma su estatus continuo como oficial y directora.

Dillard’s, Inc. (DDS)� 2025� 7� 2일자 Form 4 제출서류� 따르�, 오랜 내부자이� 부사장 � 이사� Drue Matheny가 소규� 공개시장 매수� 했습니다. 2025� 6� 30� Matheny� 주당 $413.32� 클래� A 보통� 19주를 매수하여 직접 보유 주식� 403,904�� 늘렸습니�. 또한 회사 퇴직 연금 플랜� 통해 36,648�� 보유 중이�, 간접적으� 9,821� (GST 신탁� 수탁자로� 7,300�, 배우자가 보유� 2,521�)� 보유하고 있습니다. 파생상품 거래� 보고되지 않았습니�.

이번 매수� 그녀� 직접 소유 지분의 0.005% 미만이며 DDS� 1,700� � 유통 주식수에 비해 미미하지�, 특히 고위 임원� 내부� 매수� 신뢰 신호� 해석� � 있습니다. 매도, 옵션 행사, 10b5-1 계획 신호� 없었으며, 제출서류� 그녀가 계속해서 임원 � 이사임을 확인합니�.

Le dépôt du formulaire 4 de Dillard’s, Inc. (DDS) daté du 02/07/2025 révèle un modeste achat sur le marché libre par l’initiée de longue date Drue Matheny, Vice-Présidente Exécutive et Directrice. Le 30/06/2025, Matheny a acquis 19 actions ordinaires de classe A à 413,32 $ chacune, portant sa détention directe à 403 904 actions. Elle détient également 36 648 actions via le plan de retraite de l’entreprise et 9 821 actions indirectement (7 300 en tant que fiduciaire du GST Trust et 2 521 détenues par son conjoint). Aucune transaction sur dérivés n’a été signalée.

L’achat représente moins de 0,005 % de sa détention directe et est négligeable par rapport aux 17 millions d’actions en circulation de DDS, mais tout achat par un initié—en particulier un cadre supérieur—peut être interprété comme un signe de confiance. Il n’y a eu ni ventes, ni exercices d’options, ni indications de plans 10b5-1, et le dépôt confirme son statut continu d’officier et de directrice.

Die Form 4-Meldung von Dillard’s, Inc. (DDS) vom 02.07.2025 offenbart einen bescheidenen Kauf am offenen Markt durch die langjährige Insiderin Drue Matheny, Executive Vice President und Direktorin. Am 30.06.2025 erwarb Matheny 19 Class-A-Stammaktien zu je 413,32 USD und erhöhte damit ihren direkten Anteil auf 403.904 Aktien. Zudem hält sie weiterhin 36.648 Aktien über den betrieblichen Altersvorsorgeplan sowie 9.821 Aktien indirekt (7.300 als Treuhänderin des GST Trust und 2.521 im Besitz ihres Ehepartners). Es wurden keine Derivatgeschäfte gemeldet.

Der Kauf entspricht weniger als 0,005 % ihres direkten Anteils und ist im Vergleich zu den 17 Millionen ausstehenden DDS-Aktien unerheblich, doch kann jeder Insider-Kauf � insbesondere durch einen leitenden Angestellten � als Vertrauenssignal gewertet werden. Es gab keine Verkäufe, Optionsausübungen oder Hinweise auf 10b5-1-Pläne, und die Meldung bestätigt ihren fortlaufenden Status als Führungskraft und Direktorin.

Positive
  • Open-market insider purchase signals potential management confidence in DDS shares.
  • Executive retains a large equity stake (>400k shares), aligning interests with shareholders.
Negative
  • Purchase size is immaterial (~$7.9k), limiting informational value.
  • No additional context on strategic initiatives or financial performance accompanies the filing.

Insights

TL;DR: Tiny insider buy; sentimentally positive but financially immaterial.

The 19-share purchase (~$7.9k) is negligible versus Matheny’s >400k direct shares and DDS’s $7 bn market cap. However, the direction of trade is noteworthy: insiders at DDS have historically been net sellers, so any purchase—however small—may bolster market perception of management confidence amid volatile retail conditions. With no concurrent option grants or planned sales, the filing has symbolic but limited valuation impact.

TL;DR: Governance-neutral; reaffirms insider alignment through continued equity stake.

Matheny already holds a substantial 2.4% insider stake; the incremental purchase aligns incentives but does not materially alter ownership structure. Absence of 10b5-1 designation suggests discretionary buying, which markets often view more favorably. No red flags arise, and the filing maintains transparency requirements.

Il modulo Form 4 di Dillard’s, Inc. (DDS) datato 02/07/2025 rivela un modesto acquisto sul mercato aperto da parte della veterana insider Drue Matheny, Vicepresidente Esecutivo e Direttrice. Il 30/06/2025 Matheny ha acquisito 19 azioni ordinarie di Classe A a $413,32 ciascuna, portando la sua partecipazione diretta a 403.904 azioni. Continua inoltre a detenere 36.648 azioni attraverso il piano pensionistico aziendale e 9.821 azioni indirettamente (7.300 come fiduciaria del GST Trust e 2.521 detenute dal coniuge). Non sono state segnalate transazioni su strumenti derivati.

L’acquisto rappresenta meno dello 0,005% della sua proprietà diretta ed è irrilevante rispetto alle 17 milioni di azioni in circolazione di DDS, tuttavia qualsiasi acquisto da parte di un insider—soprattutto di un dirigente senior—può essere interpretato come un segnale di fiducia. Non ci sono state vendite, esercizi di opzioni o indicazioni di piani 10b5-1, e la comunicazione conferma il suo status continuativo come dirigente e direttrice.

La presentación del Formulario 4 de Dillard’s, Inc. (DDS) con fecha 02/07/2025 revela una modesta compra en el mercado abierto por parte de la veterana insider Drue Matheny, Vicepresidenta Ejecutiva y Directora. El 30/06/2025 Matheny adquirió 19 acciones comunes Clase A a $413.32 cada una, aumentando su participación directa a 403,904 acciones. También mantiene 36,648 acciones a través del plan de jubilación de la empresa y 9,821 acciones indirectamente (7,300 como fideicomisaria del GST Trust y 2,521 en posesión de su cónyuge). No se reportaron transacciones con derivados.

La compra representa menos del 0.005% de su propiedad directa y es insignificante en relación con las 17 millones de acciones en circulación de DDS, pero cualquier compra por parte de un insider—especialmente un ejecutivo senior—puede interpretarse como una señal de confianza. No hubo ventas, ejercicios de opciones ni indicios de planes 10b5-1, y la presentación confirma su estatus continuo como oficial y directora.

Dillard’s, Inc. (DDS)� 2025� 7� 2일자 Form 4 제출서류� 따르�, 오랜 내부자이� 부사장 � 이사� Drue Matheny가 소규� 공개시장 매수� 했습니다. 2025� 6� 30� Matheny� 주당 $413.32� 클래� A 보통� 19주를 매수하여 직접 보유 주식� 403,904�� 늘렸습니�. 또한 회사 퇴직 연금 플랜� 통해 36,648�� 보유 중이�, 간접적으� 9,821� (GST 신탁� 수탁자로� 7,300�, 배우자가 보유� 2,521�)� 보유하고 있습니다. 파생상품 거래� 보고되지 않았습니�.

이번 매수� 그녀� 직접 소유 지분의 0.005% 미만이며 DDS� 1,700� � 유통 주식수에 비해 미미하지�, 특히 고위 임원� 내부� 매수� 신뢰 신호� 해석� � 있습니다. 매도, 옵션 행사, 10b5-1 계획 신호� 없었으며, 제출서류� 그녀가 계속해서 임원 � 이사임을 확인합니�.

Le dépôt du formulaire 4 de Dillard’s, Inc. (DDS) daté du 02/07/2025 révèle un modeste achat sur le marché libre par l’initiée de longue date Drue Matheny, Vice-Présidente Exécutive et Directrice. Le 30/06/2025, Matheny a acquis 19 actions ordinaires de classe A à 413,32 $ chacune, portant sa détention directe à 403 904 actions. Elle détient également 36 648 actions via le plan de retraite de l’entreprise et 9 821 actions indirectement (7 300 en tant que fiduciaire du GST Trust et 2 521 détenues par son conjoint). Aucune transaction sur dérivés n’a été signalée.

L’achat représente moins de 0,005 % de sa détention directe et est négligeable par rapport aux 17 millions d’actions en circulation de DDS, mais tout achat par un initié—en particulier un cadre supérieur—peut être interprété comme un signe de confiance. Il n’y a eu ni ventes, ni exercices d’options, ni indications de plans 10b5-1, et le dépôt confirme son statut continu d’officier et de directrice.

Die Form 4-Meldung von Dillard’s, Inc. (DDS) vom 02.07.2025 offenbart einen bescheidenen Kauf am offenen Markt durch die langjährige Insiderin Drue Matheny, Executive Vice President und Direktorin. Am 30.06.2025 erwarb Matheny 19 Class-A-Stammaktien zu je 413,32 USD und erhöhte damit ihren direkten Anteil auf 403.904 Aktien. Zudem hält sie weiterhin 36.648 Aktien über den betrieblichen Altersvorsorgeplan sowie 9.821 Aktien indirekt (7.300 als Treuhänderin des GST Trust und 2.521 im Besitz ihres Ehepartners). Es wurden keine Derivatgeschäfte gemeldet.

Der Kauf entspricht weniger als 0,005 % ihres direkten Anteils und ist im Vergleich zu den 17 Millionen ausstehenden DDS-Aktien unerheblich, doch kann jeder Insider-Kauf � insbesondere durch einen leitenden Angestellten � als Vertrauenssignal gewertet werden. Es gab keine Verkäufe, Optionsausübungen oder Hinweise auf 10b5-1-Pläne, und die Meldung bestätigt ihren fortlaufenden Status als Führungskraft und Direktorin.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lazzarato David Angelo

(Last) (First) (Middle)
C/O CANOPY GROWTH CORPORATION
1 HERSHEY DRIVE

(Street)
SMITHS FALLS A6 K7A 0A8

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Canopy Growth Corp [ CGC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 06/30/2025 S 15,701(1) D $1.23 119,064 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares reported as disposed herein were granted on June 3, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs. These RSUs vest in four equal installments on June 30, 2025, September 29, 2025, December 31, 2025 and March 31, 2026.
/s/ Shai Marshall, Attorney-in-fact for David Angelo Lazzarato 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Dillard’s (DDS) shares did Drue Matheny buy?

19 Class A shares purchased on 06/30/2025 at $413.32 each.

What is Matheny’s total direct ownership after this transaction?

She now directly owns 403,904 DDS shares.

Were any shares sold or derivatives exercised in this Form 4?

No. The filing reports only an acquisition; no sales or option exercises occurred.

Does the filing indicate a 10b5-1 trading plan?

No. The transaction is not marked as pursuant to Rule 10b5-1(c).

How many DDS shares does Matheny hold indirectly?

She controls 9,821 indirect shares: 7,300 via GST Trust and 2,521 through her spouse.
Canopy Growth Corp

NASDAQ:CGC

CGC Rankings

CGC Latest News

CGC Latest SEC Filings

CGC Stock Data

222.40M
185.21M
0.14%
6.27%
8.85%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Canada
SMITH FALLS